Eva Hellqvist

1.3k citations
13 papers · 1.1k · 1 hit paper · h-index 9

Impact in

  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research
  • Immunology top 5%
    • Immune cells in cancer
    • Immune Cell Function and Interaction
    • Phagocytosis and Immune Regulation
    • Immunodeficiency and Autoimmune Disorders
    • Immunotherapy and Immune Responses

Papers in

    • Chronic Lymphocytic Leukemia Research 4
    • Chronic Myeloid Leukemia Treatments 2

Eva Hellqvist

13 papers receiving 1.1k citations

Eva Hellqvist's Hit Papers

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis 2016 · 491 citations
4910+3+6Years since publication100200300400

Peers

Eva Hellqvist
Comparison fields: 5 of 74
  • Genetics 261
  • Immunology 521
  • Pathology and Forensic Medicine 164
  • Oncology 240
  • Hematology 75
Replace Yong‐Oon Ahn with:
Yong‐Oon Ahn South Korea
Stefano Iacovelli Italy
Man Chun John Ma United States
Susanne Hipp Germany
Leila R. Martins Portugal
Vinay Sagar United States
Stella Maris Ranuncolo United States
Guoxun Liu United States
Nicola J. Sunter United Kingdom
Danielle Ulanet United States
Eva Hellqvist relative to Yong‐Oon Ahn South Korea Yong‐Oon Ahn's profile →
Citations per field
00.5×1.5×2.2×
Yong‐Oon Ahn · 1×
Citations per year

Countries citing papers authored by Eva Hellqvist

Since Specialization
Citations

This map shows the geographic impact of Eva Hellqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellqvist more than expected).

Fields of papers citing papers by Eva Hellqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hellqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellqvist. The network helps show where Eva Hellqvist may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva Hellqvist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Hellqvist Line = papers co-authored together Eva Hellqvist links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Hit paper breakdown →
2016491
2 2008230
3 200588
4 201867
5 200858
6 201254
7 201537
8 201315
9 200814
10 20136
11 20095
12 20141
13 20121

About Eva Hellqvist

Eva Hellqvist is a scholar working on Genetics, Hematology, Immunology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Lanthanide and Transition Metal Complexes (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Advanced MRI Techniques and Applications (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Genetics (261 citations), Immunology (521 citations), Pathology and Forensic Medicine (164 citations), Oncology (240 citations) and Hematology (75 citations). Eva Hellqvist has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Anders Rosén, Malin Sund, Jeffrey V. Ravetch, Daniel Klevebring, Jonas Fuxe, Charlotte Rolny, Mikael C. I. Karlsson, Silke Sohn, Jeanette Östling and Mattias Rantalainen. Their work appears in journals such as Blood, Contrast Media & Molecular Imaging, British Journal of Cancer, OncoImmunology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact